TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$2.40
+0.17 (+7.62%)
As of Feb 8, 2:28 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,721.7% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $2.40
Current
$2.40
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
1,387.5%
Low target
Base Case
$43.72
+1,721.7%
Avg target
Bull Case
$58.20
+2,325.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$58.73
-95.9% from high
52-Week Low
$20.32
+-88.2% from low
Target vs 52W High
$43.72
-25.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%